top of page

Why isn't stroke care doing what mental health and cancer care already figures out?

  • Writer: Maya Kuzalti
    Maya Kuzalti
  • Jul 8
  • 3 min read

The economic case for lived experience has already been made - just not here, yet.


A woman sitting in a board room a bit spaced out. Behind her a group of people are discussing an agenda item.

The meeting wasn’t unkind. They rarely are.


The patient voice tends to be item seven on the agenda, somewhere between communications update and any other business. Eighteen months on from the stroke, in one of the research institutions that has invited me in as a lay stakeholder, I have been in enough of these rooms now to know that the slot on the agenda is the slot in the structure. Item seven means: we have made the decisions, we’d like you to react to them, and then we’ll move on.


So I went looking for the evidence. Not because I doubted what peer support does for someone recovering from a stroke — I’ve lived enough of it to already know. I went looking because I wanted to understand why, if the evidence is this good, lived experience still isn’t leading stroke care the way it’s starting to lead other parts of healthcare.


What I found wasn’t what I expected. The case for lived experience isn’t weak. It’s already been made, properly, with the kind of numbers that make a finance director sit up — just not in stroke. In mental health and in cancer care, someone has already done the unglamorous work of costing it out. Stroke hasn’t caught up.


Mental health is where the case is clearest. Peer support — people with their own experience of a mental health crisis, trained and paid to walk alongside someone going through one — turns out to be one of the better investments a health system can make. Fewer crises. Fewer hospital stays. People actually showing up to the appointments that keep them well instead of only the ones that happen after everything’s fallen apart.


Mental Health - The Costed Case

That’s not a soft outcome on a feelings survey. That’s beds freed up, staff time recovered, money that didn’t have to be spent twice on the same crisis.


Cancer care found its way to the same conclusion from a different angle. A programme in Alabama started training laypeople — some of them cancer survivors themselves — to walk older patients through the system: appointments, paperwork, the practical chaos nobody warns you about. Not clinical care. Just someone who understood what you were up against, on the other end of the phone.


Cancer Care - The Costed Case

So here’s the part that stopped me. I went looking for the equivalent stroke numbers. The cost savings, the readmission data, the ROI on a stroke survivor trained to walk alongside someone newly discharged.


They don’t exist.


Not because the underlying logic is any different — it isn’t. The clinical evidence for stroke is genuinely good. Trial after trial shows peer support helping people recover daily living skills, move better, feel less anxious and depressed, reconnect socially. What’s missing is the other half of the argument. Nobody has costed it. Nobody has done the stroke version of the New York study, or the Alabama study.


That's not evidence that lived experience doesn't work in stroke recovery. It's evidence that nobody with the power to fund the study has thought to ask the question.

And that’s the part I can’t quite get past. Stroke is not a small or rare event. It upends a life in roughly the time it takes to read this sentence, and the recovery afterwards is long, lonely, and full of exactly the kind of unmet need that a peer who has lived it is best placed to meet. We know this. Every stroke survivor in every support group knows this. What we don’t have, yet, is the thing that proves it to the people who control the budgets.


I think about that meeting again. Item seven. The slot in the structure.


If lived experience were genuinely leading stroke care design — not consulted at the end, but at the table when the question of what to measure gets decided — I don’t think this gap would exist. You’d ask the economic question because the person asking it would be someone who needed the answer, not someone filling a quota on a PPI panel.


The other fields didn’t get this right because they care more. They got there because someone with lived experience, or someone listening properly to people with lived experience, was close enough to the funding decision to insist the study get done.


Stroke care hasn’t had that yet. I’d like to be part of changing that.


Sources:

Comments


Get in touch!
  • LinkedIn
  • Medium
  • Substack

Connect with me on LinkedIn

Follow me on Medium @mayakuzalti

Follow me on Substack @mayakuzalti

(c) 2026 Maya Kuzalti. All Rights Reserved.

bottom of page